Modi, Zubin J.
Zhai, Yan
Yee, Jennifer
Desmond, Hailey
Hao, Wei
Sampson, Matthew G.
Sethna, Christine B.
Wang, Chia-shi
Gipson, Debbie S.
Trachtman, Howard http://orcid.org/0009-0006-7778-292X
Kretzler, Matthias
Massengill, Susan
Lo, Layla
Dell, Katherine
O’Toole, John
Sedor, John
Martin, Blair
Macumber, Ian
Sharma, Silpa
Srivastava, Tarak
Markus, Kelsey
Vento, Suzanne
Canetta, Pietro
Olabisi, Opeyemi
Gbadegesin, Rasheed
Smith, Maurice
Greenbaum, Laurence
Yun, Emily
Adler, Sharon
LaPage, Janine
Amarah, Amatur
Itteera, Mathew
Atkinson, Meredith
Williams, Miahje
Lieske, John
Hogan, Marie
Fervenza, Fernando
Selewski, David
Alston, Cheryl
Reidy, Kim
Ross, Michael
Kaskel, Frederick
Flynn, Patricia
Malaga-Dieguez, Laura
Zhdanova, Olga
Pehrson, Laura Jane
Miranda, Melanie
Almaani, Salem
Roberts, Laci
Lafayette, Richard
Dave, Shiktij
Lee, Iris
Shah, Shweta
Batla, Sadaf
Reich, Heather
Hladunewich, Michelle
Ling, Paul
Romano, Martin
Brakeman, Paul
Dylewski, James
Rogers, Nathan
McCarthy, Ellen
Creed, Catherine
Fornoni, Alessia
Bandes, Miguel
Mariani, Laura
Williams, A.
Ni, Roxy
Nachman, Patrick
Rheault, Michelle
Kowalski, Amy
Rauwolf, Nicolas
Derebail, Vimal
Gibson, Keisha
Froment, Anne
Kelley, Sara
Holzman, Lawrence
Meyers, Kevin
Kallem, Krishna
Edwards, Aliya
Sharma, Samin
Roehm, Elizabeth
Sambandam, Kamalanathan
Brown, Elizabeth
Hellewege, Jamie
Jefferson, Ashley
Hingorani, Sangeeta
Tuttle, Katherine
Manahan, Linda
Pao, Emily
Kuykendall, Kelli
Lin, Jen Jar
Dharnidharka, Vikas
Gillespie, Brenda
Salmon, Eloise
Mainieri, Tina
Alter, Gabrielle
Arbit, Michael
Eddy, Sean
Fermin, Damian
Ju, Wenjun
Larkina, Maria
Lienczewski, Chrysta
Scherr, Rebecca
Troost, Jonathan
Williams, Amanda
Kincaid, Colleen
Li, Shengqian
Li, Shannon
Gadegbeku, Crystal
Barisoni, Laura
Smith, Abigail
Zee, Jarcy
Avila-Casado, Carmen
Bagnasco, Serena
Bu, Lihong
Caltharp, Shelley
Cassol, Clarissa
Demeke, Dawit
Hassler, Jared
Herlitz, Leal
Hewitt, Stephen
Hodgin, Jeff
Holanda, Danni
Kambham, Neeraja
Lemley, Kevin
Messias, Nidia
Mikhailov, Alexei
Moreno, Vanessa
Najafian, Behzad
Palmer, Matthew
Rosenberg, Avi
Royal, Virginie
Sekulik, Miroslav
Stokes, Barry
Thomas, David
Wu, Ming
Yamashita, Michifumi
Yin, Hong
Zuo, Yiqin
Nast, Cynthia
,
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (U54DK083912)
National Center for Advancing Translational Sciences (U2CTR002818)
National Institutes of Health (R01DK119380, 2U54DK083912, RC2DK122397)
Article History
Received: 16 October 2023
Revised: 20 November 2023
Accepted: 5 December 2023
First Online: 18 January 2024
Declarations
:
: Dr. Modi reports research funding outside of this work from the National Institutes of Health, Centers for Disease Control, the Patient-Centered Outcomes Research Institute, Travere Therapeutics, and Boehringer Ingelheim. He is also the current director of the Kidney Research Network Coordinating Center. Dr. Sampson is on the scientific advisory board of Natera. Dr Wang received research support from the National Institute of Diabetes and Digestive and Kidney Diseases, the Centers for Disease Control and Prevention, NephCure Kidney International (NKI), the European Society of Pediatric Nephrology—Pediatric Nephrology Research Consortium, Boehringer-Ingelheim, IQVIA, and Genentech outside the submitted work. Dr. Gipson reports past research funding from National Institutes of Health, Centers for Disease Control, US Food and Drug Administration, Travere Therapeutics, Reata, Novartis, and Boehringer Ingelheim; past consulting fees paid to the University of Michigan form Roche/Genentech and Vertex; past participation in Data Safety Monitoring Board for National Institutes of Health; past director of Kidney Research Network Coordinating Center; and unpaid project co-lead of the National Kidney Foundation improving vaccination in the kidney disease community project, past co-lead of the Kidney Health Initiative Pediatric IgA nephropathy project, past member of the Kidney Health Initiative FSGS outcomes project, and past planning committee member for the NephCure and Kidney Health Initiative sponsored workshop entitled Pathways to SGLT2i for renoprotection in pediatric CKD. Dr. Trachtman reports employment with RenalStrategies LLC. He has active consultancy agreements with Aclipse, Angion, Goldfinch Bio, Maze Therapeutics, Natera (RenaSight), Otsuka (DSMB Chair for Pediatric Trials), Travere Therapeutics, Inc., Boehringer-Ingelheim, PhaseV and Walden; honoraria for participation in glomerular disease panels organized by Astellas and Reata; Steering Committee and Scientific Advisory Board for DUPRO (DUPLEX and POTECT Trials) for Travere Therapeutics, Inc.; member of the Kidney Health Initiative Board of Directors; Editorial board member of Pediatric Nephology, Glomerular Diseases, and Kidney360; serves as a partner with NephCure Kidney International in efforts to promote pediatric participation in clinical trials for glomerular diseases (PIONEER). Dr. Kretzler reports grants from NIH, non-financial support from University of Michigan, funding through the University of Michigan from Goldfinch Bio, Boehringer-Ingelheim, Certa, Travere and Maze therapeutics, as well as grants and contracts outside the submitted work through the University of Michigan with NIH, Chan Zuckerberg Initiative, JDRF, Roche, Astra-Zeneca, NovoNordisk, Moderna, European Union Innovative Medicine, Chinook, Angion Pharmaceuticals, RenalytixAI, Eli Lilly, Gilead, Regeneron, IONIS, and Janssen; consulting fees through the University of Michigan from Astellas, Poxel, Janssen, NovoNordisc; and serves on the NIH-NCATS council and the NephCure Kidney International Board. In addition, Dr. Kretzler has a patent PCT/EP2014/073413 “Biomarkers and methods for progression prediction for chronic kidney disease” licensed. All other authors have no disclosures to report.